Tissue engineering technology for articular cartilage repair: how to construct a new compound pattern?

doi:10.3969/j.issn.2095-4344.2015.29.028

Abstract

Abstract:

BACKGROUND: Articular cartilage has limited ability to repair itself, and the traditional means are difficult to repair articular cartilage defects, but articular cartilage tissue engineering provides new methods and approaches for large-area articular cartilage defects.

OBJECTIVE: To review the current status, problems and prospects of tissue engineering technology in articular cartilage repair.

METHODS: The retrieval of PubMed database was performed for articles published from 1982 to 2015, with the keywords of “articular cartilage, repair, tissue engineering” in English. Literatures related to tissue engineering repair of articular cartilage were included, but repetitive studies were excluded. Finally 39 articles were reserved in result analysis.

RESULTS AND CONCLUSION: Excellent seed cells have chondrogenic differentiation potential, and currently, the main seed cells for articular cartilage repair include mesenchymal stem cells, embryonic stem cells, adipose-derived stem cells and precartilaginous stem cells. Different growth factors, which can induce the in vivo growth of host parenchymal cells, improve seeded cell stability, and accelerate tissue regeneration, tend to be combined in clinical application. Composite scaffolds are also one of hot researches that can promote cell inoculation and spatial distribution as well as accelerate cell proliferation. To obtain the best effectiveness of articular cartilage repair, how to optimize seed cells, select and match scaffold materials to construct new types of composite patterns is an important direction in the future.

中国组织工程研究杂志出版内容重点：组织构建；骨细胞；软骨细胞；细胞培养；成纤维细胞；血管内皮细胞；骨质疏松；组织工程

Key words: Cartilage, Articular;, Stem Cells, Stents, Cytokines

CLC Number:

R318

Yang Rui-tao, Song Hui-ping. Tissue engineering technology for articular cartilage repair: how to construct a new compound pattern? [J]. Chinese Journal of Tissue Engineering Research, 2015, 19(29): 4736-4741.

Figures/Tables 1

References

[1] Emans PJ, Surtel DA, Frings EJ, et al.In vivo generation of cartilage from periosteum. Tissue Eng.2005;11(3-4):369-377.

[2] Steadman JR, Briggs KK, Rodrigo JJ, et al.Outcomes of microfracture for traumatic chondral defects of the knee: average 11-year follow-up. Arthroscopy. 2003;19(5):477-484.

[3] Mobasheri A, Kalamegam G, Musumeci G, et al. Chondrocyte and mesenchymal stem cell-based therapies for cartilage repair in osteoarthritis and related orthopaedic conditions. Maturitas.2014;78(3):188-198.

[4] Goldberg AJ, Lee DA, Bader DL，et al.Autologous chondrocyte implantation. Culture in a TGF-beta-containing medium enhances the re-expression of a chondrocytic phenotype in passaged human chondrocytes in pellet culture. J Bone Joint Surg Br. 2005;87(1):128-134.

[5] BaqhabanEslaminejad M, Malakooty Poor E. Mesenchymal stem cells as a potent cell source for articular cartilage regeneration. World J Stem Cells.2014;6(3):344-354.

[6] Bornes TD, Adesida AB, Jomha NM. Mesenchymal stem cells in the treatment of traumatic articular cartilage defects: a comprehensive review. Arthritis Res Ther. 2014;16(5): 432.

[7] Fridenshte?n AIa. Stromal bone marrow cells and the hematopoietic microenvironment.Arkh Patol.1982;44:3-11.

[8] Song Z, Wu C, Sun S, et al. Quantitative analysis of factors influencing tissue-engineered bone formation by detecting the expression levels of alkaline phosphatase and bone γ-carboxyglutamate protein 2. ExpTher Med.2015;9(4): 1097-1102.

[9] Zhu L, Jiang H, Zhou GD, et al. Preliminary study of constructing tissue-engineered cartilage with the endoskeletal scaffold of HDPE by bone marrow stromal cells. Zhonghua Zheng Xing WaiKeZaZhi. 2008;24(5):377-381.

[10] Stromps JP, Paul NE，Rath B，et al. Chondrogenic differentiation of human adipose-derived stem cells: a new path in articular cartilage defect management? Biomed Res Int.2014;2014:740926.

[11] Peppo GM, Svensson S, LennerasM, et al. Human embryonic mesodermal progenitors highly resemble human mesenchymal stem cells and display high potential for tissue engineering applications. Tissue Eng Part A.2010; 16(7):2161-2182.

[12] Toh WS, Lee EH, Guo XM, et al. Cartilage repair using hyaluronan hydrogel-encapsulated human embryonic stem cell-derived chondrogenic cells. Biomaterials.2010;31(27): 6968-6980.

[13] Wu L, Bluguermann C, Kyupelyan L, et al. Human developmental chondrogenesis as a basis for engineering chondrocytes from pluripotent stem cells. Stem Cell Reports. 2013;1(6):575-89.

[14] Nejadnik H, Diecke S, Lenkov OD, et al. Improved Approach for Chondrogenic Differentiation of Human Induced Pluripotent Stem Cells. Stem Cell Rev. 2015Jan 13. [Epub ahead of print]

[15] Medvedev SP, Grigor'eva EV, Shevchenko AI, et al. Human induced pluripotent stem cells derived from fetal neural stem cells successfully undergo directed differentiation into cartilage. Stem Cells Dev.2011;20(6):1099-112.

[16] Nestor MW, Paull D, Jacob S, et al. Differentiation of serum-free embryoid bodies from human induced pluripotent stem cells into networks. Stem Cell Res. 2013; 10(3):454-63.

[17] Taghiabadi E, Nasri S, Shafieyan S, et al. Fabrication and characterization of spongy denuded amniotic membrane based scaffold for tissue engineering.Cell J. 2015;16(4): 476-87.

[18] Sridhar BV, Brock JL, Silver JS，et al. Development of a Cellularly Degradable PEG Hydrogel to Promote Articular Cartilage Extracellular Matrix Deposition.AdvHealthc Mater.2015 Jan 21.

[19] Nanda HS, Chen S, Zhang Q, et al. Collagen scaffolds with controlled insulin release and controlled pore structure for cartilage tissue engineering. Biomed Res Int. 2014;2014: 623805.

[20] Yan S, Wang T, Feng L, et al. Injectable in situ self-crosslinking hydrogels based on poly(L-glutamic acid)and alginate for cartilage tissue engineering. Biomacromolecules. 2014;15(12):4495-508.

[21] Stocco E, Barbon S, Dalzoppo D, et al. Tailored PVA/ECM Scaffolds for Cartilage Regeneration. Biomed Res Int.2014: 762189.

[22] Wang YC, Meng HY, Yuan XL, et al. Fabrication and in vitro evaluation of an articular cartilage extracellular matrix-hydroxyapatite bilayered scaffold with low permeability for interface tissue engineering. BioMedical Engineering Online.2014;13:80.

[23] Liu J, Nie H, Xu Z, et al.The effect of 3D nano fibrous scaffolds on the chondrogenesis of induced pluripotent stem cells and their application in restoration of cartilage defects. PLoS One.2014;9(11):e111566.

[24] Chaudhury K, Kumar V, Kandasamy J, et al.Regenerative nanomedicine: current perspectives and future directions. Int J Nanomedicine,2014;9:4153-4167.

[25] Lim EH, Sardinha JP, Myers S. Nanotechnology Biomimetic Cartilage Regenerative Scaffolds. Arch Plast Surg.2014; 41(3):231-240.

[26] Gu M, Liu Y, Chen T, Du F, et al.Is graphene a promising nano-material for promoting surface modification of implants or scaffold materials in bone tissue engineering? Tissue Eng Part B Rev.2014;20(5):477-491.

[27] Lee WC, Lim CH, Kenry, et al. Cell-assembled graphene biocomposite for enhanced chondrogenic differentiation. Small.2015;11(8):963-969.

[28] Klangjorhor J, Phitak T, Pruksakorn D, et al. Comparison of growth factor adsorbed scaffold and conventional scaffold with growth factor supplemented media for primary human articular chondrocyte 3D culture. BMC Biotechnol. 2014; 14(1):959.

[29] Murphy MK, Huey DJ, Hu JC, et al. TGF-β1, GDF-5, and BMP-2 Stimulation Induces Chondrogenesis in Expanded Human Articular Chondrocytes and Marrow-Derived Stromal Cells. Stem Cells.2015;33(3):762-773.

[30] Frisch J,Venkatesan JK, Rey-Rico A, et al. Determination of the chondrogenic differentiation processes in human bone marrow-derived mesenchymal stem cells genetically modified to overexpress transforming growth factor-β via recombinant adeno-associated viral vectors. Hum Gene Ther. 2014;25(12): 1050-1060.

[31] Rocha PM, Santo VE, Gomes ME, et al.Encapsulation of adipose-derived stem cells and transforming growth factor-1in carrageenan-based hydrogels for cartilage tissue engineering. J BioactCompatPolym, 2011;26 (5): 493-507.

[32] Karl A, Olbrich N, Pfeifer C, et al. Thyroid hormone-induced hypertrophy in mesenchymal stem cell chondrogenesis is mediated by bone morphogenetic protein-4. Tissue Eng Part A.2014;20(1-2):178-188.

[33] Jiang Y, Chen LK, Zhu DC, et al. The inductive effect ofbone morphogenetic protein-4 on chondral-lineage differentiation and in situ cartilage repair. Tissue Eng Part A.2010;16(5): 1621-32.

[34] Elder S, Thomason J. Effect of Platelet-Rich Plasma on Chondrogenic Differentiation in three-dimensional culture. Open Orthop J. 2014 ;8:78-84.

[35] Mascarenhas R, Saltzman BM, Fortier LA, et al. Role of platelet-rich plasma in articular cartilage injury and disease. J Knee Surg.2015;28(1):3-10.

[36] Wang Y, Kim UJ, Blasioli DJ, et al. In vitro cartilage tissue engineering with 3D porous aqueous-derived silk scaffolds and mesenchymal stem cells.Biomaterials. 2005;26: 7082-7094.

[37] Man Z, Yin L, Shao Z, et al. The effects of co-delivery of BMSC-affinity peptide and rhTGF-β1 from coaxial electrospun scaffolds on chondrogenic differentiation. Biomaterials. 2014; 35(19):5250-5360.

[38] Zhu L, Wu Y, Jiang H, et al.Engineered cartilage with internal porous high-density polyethylene support from bone marrow stromal cells: A preliminary study in nude mice.Br J Oral Maxillofac Surg.2010;48(6):462-465.

[39] Araki S, Imai S, Ishigaki H, et al.Improved quality of cartilage repair by bone marrow mesenchymal stem cells for treatment of an osteochondral defect in a cynomolgus macaque model. ActaOrthop.2015;86(1):119-126.